Fast Titration in the Treatment of Schizophrenia, Taiwan
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00304473|
Recruitment Status : Completed
First Posted : March 20, 2006
Last Update Posted : March 25, 2009
Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Drug: Quetiapine fumarate||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Fast Titration of Quetiapine Versus Conventional Titration in the Treatment of Schizophrenia/Schizoaffective Disorder: a Randomised, Parallel Group Open Trial|
|Study Start Date :||August 2004|
|Actual Study Completion Date :||April 2006|
- Compare the safety and tolerability of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
- Assess the efficacy of a fast titration of quetiapine to the current titration approved by the regulatory authorities.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00304473
|Study Director:||AstraZeneca Taiwan Medical Director, MD||AstraZeneca|